Review

Published on 13 Aug 2021

The Role of miR-181c in Mechanisms of Diabetes-Impaired Angiogenesis: An Emerging Therapeutic Target for Diabetic Vascular Complications

in Translational Pharmacology

Emma L. Solly
Peter J. Psaltis
Christina A. Bursill
Joanne T. M. Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2021.718679

4,484 views
16 citations

Original Research

Published on 10 Aug 2021

Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics

in Translational Pharmacology

Ana Copaescu
Phuti Choshi
Sarah Pedretti
Effie Mouhtouris
Jonathan Peter
Jason A. Trubiano

Frontiers in Pharmacology

doi 10.3389/fphar.2021.640012

4,329 views
11 citations

Original Research

Published on 06 Aug 2021

The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models

in Translational Pharmacology

Scott P. Davies
Courtney J. Mycroft-West
Isabel Pagani
Harriet J. Hill
Yen-Hsi Chen
Richard Karlsson
Ieva Bagdonaite
Scott E. Guimond
Zania Stamataki
Marcelo Andrade De Lima

Frontiers in Pharmacology

doi 10.3389/fphar.2021.660490

79,380 views
38 citations

Original Research

Published on 06 Aug 2021

An Integrated Metabolomic Study of Osteoporosis: Discovery and Quantification of Hyocholic Acids as Candidate Markers

in Translational Pharmacology

Dawei Deng
Chen Pan
Zeming Wu
Yujiao Sun
Chang Liu
Hong Xiang
Peiyuan Yin
Dong Shang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.725341

4,966 views
24 citations

Review

Published on 05 Aug 2021

Pain Treatment in the Companion Canine Model to Validate Rodent Results and Incentivize the Transition to Human Clinical Trials

in Translational Pharmacology

Michael J. Iadarola
Dorothy Cimino Brown
Alexis Nahama
Matthew R. Sapio
Andrew J. Mannes

Frontiers in Pharmacology

doi 10.3389/fphar.2021.705743

6,152 views
12 citations

Original Research

Published on 04 Aug 2021

Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics

in Translational Pharmacology

Bérénice Charrez
Verena Charwat
Brian A. Siemons
Ishan Goswami
Courtney Sakolish
Yu-Syuan Luo
Henrik Finsberg
Andrew G. Edwards
Evan W. Miller
Ivan Rusyn

Frontiers in Pharmacology

doi 10.3389/fphar.2021.684252

5,908 views
15 citations

Mini Review

Published on 28 Jul 2021

Functions and Diseases of the Retinal Pigment Epithelium

in Translational Pharmacology

Song Yang
Jun Zhou
Dengwen Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.727870

99,646 views
142 citations

Review

Published on 26 Jul 2021

CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy

in Translational Pharmacology

Christopher R. Veitch
Amelia S. Power
Jeffrey R. Erickson

Frontiers in Pharmacology

doi 10.3389/fphar.2021.695401

6,900 views
13 citations

Mini Review

Published on 26 Jul 2021

Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing

in Translational Pharmacology

Wei-Yang Chen
Eric A Evangelista
Jade Yang
Edward J Kelly
Catherine K Yeung

Frontiers in Pharmacology

doi 10.3389/fphar.2021.695920

11,468 views
27 citations

Review

Published on 22 Jul 2021

H2S Donor and Bone Metabolism

in Translational Pharmacology

Yanming Hao
Hongzhen Wang
Lingna Fang
Jinsong Bian
Yan Gao
Chong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.661601

7,207 views
24 citations

Clinical Trial

Published on 22 Jul 2021

First-in-Human, Double-Blind, Randomized, Placebo-Controlled Trial of TQ-F3083, a New Dipeptidyl Peptidase-4 Inhibitor, in Healthy Chinese Adults

in Translational Pharmacology

Jingrui Liu
Xiaoxue Zhu
Hong Zhang
Haijing Wei
Deming Yang
Zhongnan Xu
Dandan Huo
Xiaojiao Li
Yanhua Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2021.689523

2,656 views
6 citations

Original Research

Published on 20 Jul 2021

Pharmacotherapy for Behçet’s Disease and the Risk of Malignancy

in Translational Pharmacology

Mao-Xin Huang
Cai-Yun Wang
Jin-Yan Guo
Jian-Hao Li
Xiao-Hong Li
Jiang-An Zhang
Jian-Bin Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.661150

3,180 views
8 citations

Review

Published on 19 Jul 2021

Corneal Cross-Linking: The Evolution of Treatment for Corneal Diseases

in Translational Pharmacology

Duoduo Wu
Dawn Ka-Ann Lim
Blanche Xiao Hong Lim
Nathan Wong
Farhad Hafezi
Ray Manotosh
Chris Hong Long Lim

Frontiers in Pharmacology

doi 10.3389/fphar.2021.686630

22,318 views
38 citations

Clinical Trial

Published on 19 Jul 2021

Comparison of the Safety and Efficacy of Interferon Alpha-2a and Cyclosporine-A When Combined With Glucocorticoid in the Treatment of Refractory Behçet’s Uveitis: A Randomized Controlled Prospective Study

in Translational Pharmacology

Yujing Qian
Yi Qu
Fei Gao
Minghang Pei
Anyi Liang
Junyan Xiao
Chan Zhao
Meifen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.699903

3,222 views
16 citations

Original Research

Published on 15 Jul 2021

Plasma Amino Acids Metabolomics' Important in Glucose Management in Type 2 Diabetes

in Translational Pharmacology

Abdelrahim Alqudah
Mohammed Wedyan
Esam Qnais
Hassan Jawarneh
Lana McClements

Frontiers in Pharmacology

doi 10.3389/fphar.2021.695418

9,291 views
37 citations

Original Research

Published on 14 Jul 2021

Norswertianolin Promotes Cystathionine γ-Lyase Activity and Attenuates Renal Ischemia/Reperfusion Injury and Hypertension

in Translational Pharmacology

Yaping Niu
Congkuo Du
Changting Cui
Haizeng Zhang
Yue Deng
Jun Cai
Zhenzhen Chen
Bin Geng

Frontiers in Pharmacology

doi 10.3389/fphar.2021.677212

3,874 views
4 citations

Navigation group

Articles

The Role of miR-181c in Mechanisms of Diabetes-Impaired Angiogenesis: An Emerging Therapeutic Target for Diabetic Vascular Complications

Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics

The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models

An Integrated Metabolomic Study of Osteoporosis: Discovery and Quantification of Hyocholic Acids as Candidate Markers

Pain Treatment in the Companion Canine Model to Validate Rodent Results and Incentivize the Transition to Human Clinical Trials

Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics

Functions and Diseases of the Retinal Pigment Epithelium

CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy

Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing

H2S Donor and Bone Metabolism

First-in-Human, Double-Blind, Randomized, Placebo-Controlled Trial of TQ-F3083, a New Dipeptidyl Peptidase-4 Inhibitor, in Healthy Chinese Adults

Pharmacotherapy for Behçet’s Disease and the Risk of Malignancy

Corneal Cross-Linking: The Evolution of Treatment for Corneal Diseases

Comparison of the Safety and Efficacy of Interferon Alpha-2a and Cyclosporine-A When Combined With Glucocorticoid in the Treatment of Refractory Behçet’s Uveitis: A Randomized Controlled Prospective Study

Plasma Amino Acids Metabolomics' Important in Glucose Management in Type 2 Diabetes

Norswertianolin Promotes Cystathionine γ-Lyase Activity and Attenuates Renal Ischemia/Reperfusion Injury and Hypertension